查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1596754

類固醇注射市場：按產品類型、給藥途徑、分銷管道和應用分類 - 全球預測 2025-2030

Steroid Injections Market by Product Type (Cortisone, Hydrocortisone, Methylprednisolone), Administration Route (Epidural, Intra-Articular, Intramuscular), Distribution Channel, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

類固醇注射市場2023年估值為38億美元，預計2024年將達42.9億美元，複合年成長率為13.54%，預計到2030年將達到92.5億美元。

類固醇注射是一種將皮質類固醇直接注射到身體發炎或疼痛部位以抑制發炎和疼痛的治療方法。這些注射對於關節炎、肌腱炎和黏液囊炎等疾病至關重要，可以大大緩解症狀並改善活動能力，對於對其他治療沒有反應的患者來說是必要的。類固醇注射用於各種醫療環境，包括醫院門診、診所和私人診所，最終用戶範圍從整形外科專家到運動醫生。由於肌肉骨骼疾病的盛行率不斷增加、老年人口的增加以及對微創手術的需求不斷增加，類固醇注射市場正在不斷成長。藥物輸送系統的技術進步和新型皮質類固醇的開發為市場參與者提供了利潤豐厚的機會。透過策略夥伴關係和研發投資解決這些問題可以提高您的市場佔有率。然而，存在一些限制，例如可能的副作用、嚴格的監管要求以及物理復健和口服藥物等替代療法的可用性，這些可能會阻礙市場成長。為了推動創新，公司應專注於改進可改善患者治療效果的注射藥物配方，並探索最大限度減少副作用的下一代給藥技術。由於醫療基礎設施的改善和先進治療解決方案意識的提高，新興市場提供了成長潛力，使得對這些地區的投資具有戰略意義。儘管面臨挑戰，類固醇注射市場的性質仍然強勁，這得益於對有效疼痛管理和發炎控制療法的持續需求。隨著技術創新，對患者需求和醫療保健趨勢的全面了解可以為在這個競爭激烈的市場環境中擴展和適應提供重要的機會。

主要市場統計
基準年[2023] 38億美元
預測年份 [2024] 42.9億美元
預測年份 [2030] 92.5億美元
複合年成長率（%） 13.54%

市場動態：揭示快速發展的類固醇注射市場的關鍵市場洞察

供需的動態交互作用正在改變類固醇注射市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 整形外科疾病的發生導致老年人口增加
    • 健身運動在年輕人中越來越受歡迎
  • 市場限制因素
    • 對類固醇注射使用的嚴格規定
  • 市場機會
    • 整形外科手術的吸引力日益成長
    • 類固醇注射的引入和核准
  • 市場挑戰
    • 與類固醇消耗相關的不良副作用

波特的五力：駕馭類固醇注射市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解類固醇注射市場的外部影響

外部宏觀環境因素在塑造類固醇注射劑市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解類固醇注射市場的競爭狀況

類固醇注射市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位基質類固醇注射市場供應商的績效評估

FPNV定位矩陣是評估類固醇注射市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃類固醇注射市場的成功之路

類固醇注射市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 老年人口增加與整形外科疾病發生
      • 健身運動深受年輕人喜愛
    • 抑制因素
      • 關於使用類固醇注射的嚴格規定
    • 機會
      • 人們對整容手術的興趣日益濃厚
      • 類固醇注射的引入和核准
    • 任務
      • 與服用類固醇相關的有害副作用
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章類固醇注射市場：依產品類型

  • 可的松
  • Hydrocortisone
  • Methylprednisolone
  • 去炎松

第7章依給藥途徑的類固醇注射市場

  • 硬脊膜外麻醉
  • 關節內的
  • 肌肉注射
  • 靜脈

第8章類固醇注射市場：依通路分類

  • 醫院藥房
  • 零售藥房
  • 專科診所

第9章類固醇注射市場：依應用分類

  • 僵直性脊椎炎
  • 腰痛
  • 黏液囊炎
  • 癌症
  • 痛風
  • 骨關節炎
  • 乾癬性關節炎
  • 類風濕性關節炎

第10章 北美、南美類固醇注射市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太類固醇注射市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲類固醇注射市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
  • 戰略分析和建議

公司名單

  • Actiza Pharmaceutical Private Limited
  • AdvaCare Pharma
  • ANI Pharmaceuticals, Inc.,
  • Bristol-Myers Squibb Company
  • Farmabios GmbH
  • Flagship Biotech International Private Limited.
  • Flexion Therapeutics Inc.
  • GSK plc
  • Health Biotech Limited
  • Intrapharm Laboratories
  • Merck & Co., Inc.
  • Merit Healthcare International Inc.
  • Mylan NV
  • Novartis AG
  • Perrigo Company plc
Product Code: MRR-4103B31E091F

The Steroid Injections Market was valued at USD 3.80 billion in 2023, expected to reach USD 4.29 billion in 2024, and is projected to grow at a CAGR of 13.54%, to USD 9.25 billion by 2030.

Steroid injections are a medical treatment involving the administration of corticosteroids directly into inflamed or painful areas in the body to reduce inflammation and pain. Essential for conditions like arthritis, tendonitis, and bursitis, these injections provide significant relief and improve mobility, making them necessary for patients unresponsive to other treatments. Steroid injections are applied in various medical settings, including hospital outpatient departments, clinics, and private medical practices, with end-users ranging from orthopedic specialists to sports medicine practitioners. The market for steroid injections is witnessing growth driven by the increasing prevalence of musculoskeletal disorders, the rising geriatric population, and growing demand for minimally invasive procedures. Technological advancements in drug delivery systems and the development of novel corticosteroids present lucrative opportunities for market players. Addressing these through strategic partnerships and R&D investments can enhance market presence. However, the market faces limitations such as the potential for side effects, stringent regulatory requirements, and the availability of alternative therapies like physical rehabilitation and oral medications, which can hinder growth. To drive innovation, companies should focus on improving the formulation of injectable drugs for better patient outcomes and explore next-generation delivery technologies that minimize adverse effects. Markets in emerging economies offer potential growth due to increasing healthcare infrastructure and rising awareness of advanced therapeutic solutions, suggesting investment in these regions would be strategic. Despite challenges, the nature of the steroid injection market remains robust, sustained by continuous demand for effective pain management and inflammation control therapies. A comprehensive understanding of patient needs and healthcare trends, alongside technological innovation, can offer substantial opportunities for expansion and adaptation in this competitive market landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 3.80 billion
Estimated Year [2024] USD 4.29 billion
Forecast Year [2030] USD 9.25 billion
CAGR (%) 13.54%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Steroid Injections Market

The Steroid Injections Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing geriatric population along with occurrences of orthopedic disorders
    • Popularity of bodybuilding among young people
  • Market Restraints
    • Stringent regulation for steroid injection usage
  • Market Opportunities
    • Growing attraction towards plastic surgeries
    • Introduction and approval of the steroid injections
  • Market Challenges
    • Harmful side effects associated with the consumption of steroids

Porter's Five Forces: A Strategic Tool for Navigating the Steroid Injections Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Steroid Injections Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Steroid Injections Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Steroid Injections Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Steroid Injections Market

A detailed market share analysis in the Steroid Injections Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Steroid Injections Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Steroid Injections Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Steroid Injections Market

A strategic analysis of the Steroid Injections Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Steroid Injections Market, highlighting leading vendors and their innovative profiles. These include Actiza Pharmaceutical Private Limited, AdvaCare Pharma, ANI Pharmaceuticals, Inc.,, Bristol-Myers Squibb Company, Farmabios GmbH, Flagship Biotech International Private Limited., Flexion Therapeutics Inc., GSK plc, Health Biotech Limited, Intrapharm Laboratories, Merck & Co., Inc., Merit Healthcare International Inc., Mylan N.V., Novartis AG, and Perrigo Company plc.

Market Segmentation & Coverage

This research report categorizes the Steroid Injections Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Cortisone, Hydrocortisone, Methylprednisolone, and Triamcinolone.
  • Based on Administration Route, market is studied across Epidural, Intra-Articular, Intramuscular, and Intravenous.
  • Based on Distribution Channel, market is studied across Hospital Pharmacy, Retail Pharmacy, and Specialty Clinics.
  • Based on Application, market is studied across Ankylosing Spondylitis, Back pain, Bursitis, Cancer, Gout, Osteoarthritis, Psoriatic Arthritis, and Rheumatoid Arthritis.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing geriatric population along with occurrences of orthopedic disorders
      • 5.1.1.2. Popularity of bodybuilding among young people
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulation for steroid injection usage
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing attraction towards plastic surgeries
      • 5.1.3.2. Introduction and approval of the steroid injections
    • 5.1.4. Challenges
      • 5.1.4.1. Harmful side effects associated with the consumption of steroids
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Steroid Injections Market, by Product Type

  • 6.1. Introduction
  • 6.2. Cortisone
  • 6.3. Hydrocortisone
  • 6.4. Methylprednisolone
  • 6.5. Triamcinolone

7. Steroid Injections Market, by Administration Route

  • 7.1. Introduction
  • 7.2. Epidural
  • 7.3. Intra-Articular
  • 7.4. Intramuscular
  • 7.5. Intravenous

8. Steroid Injections Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacy
  • 8.3. Retail Pharmacy
  • 8.4. Specialty Clinics

9. Steroid Injections Market, by Application

  • 9.1. Introduction
  • 9.2. Ankylosing Spondylitis
  • 9.3. Back pain
  • 9.4. Bursitis
  • 9.5. Cancer
  • 9.6. Gout
  • 9.7. Osteoarthritis
  • 9.8. Psoriatic Arthritis
  • 9.9. Rheumatoid Arthritis

10. Americas Steroid Injections Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Steroid Injections Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Steroid Injections Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Actiza Pharmaceutical Private Limited
  • 2. AdvaCare Pharma
  • 3. ANI Pharmaceuticals, Inc.,
  • 4. Bristol-Myers Squibb Company
  • 5. Farmabios GmbH
  • 6. Flagship Biotech International Private Limited.
  • 7. Flexion Therapeutics Inc.
  • 8. GSK plc
  • 9. Health Biotech Limited
  • 10. Intrapharm Laboratories
  • 11. Merck & Co., Inc.
  • 12. Merit Healthcare International Inc.
  • 13. Mylan N.V.
  • 14. Novartis AG
  • 15. Perrigo Company plc

LIST OF FIGURES

  • FIGURE 1. STEROID INJECTIONS MARKET RESEARCH PROCESS
  • FIGURE 2. STEROID INJECTIONS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL STEROID INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL STEROID INJECTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. STEROID INJECTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. STEROID INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. STEROID INJECTIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL STEROID INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL STEROID INJECTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. STEROID INJECTIONS MARKET DYNAMICS
  • TABLE 7. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL STEROID INJECTIONS MARKET SIZE, BY CORTISONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HYDROCORTISONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL STEROID INJECTIONS MARKET SIZE, BY METHYLPREDNISOLONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TRIAMCINOLONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL STEROID INJECTIONS MARKET SIZE, BY EPIDURAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INTRA-ARTICULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ANKYLOSING SPONDYLITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BURSITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL STEROID INJECTIONS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL STEROID INJECTIONS MARKET SIZE, BY GOUT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL STEROID INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PSORIATIC ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. MALAYSIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. PHILIPPINES STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. SINGAPORE STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. SOUTH KOREA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. TAIWAN STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. THAILAND STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. VIETNAM STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. DENMARK STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. EGYPT STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. FINLAND STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. FRANCE STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. GERMANY STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. ISRAEL STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. ITALY STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. NETHERLANDS STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 149. NIGERIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. NORWAY STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 157. POLAND STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 161. QATAR STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 165. RUSSIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. SAUDI ARABIA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH AFRICA STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 177. SPAIN STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. SWEDEN STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 185. SWITZERLAND STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 189. TURKEY STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED ARAB EMIRATES STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM STEROID INJECTIONS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. STEROID INJECTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 199. STEROID INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2023